Showing results (51-60 of 281) with videos related to
Sort By:
Pageof 29
Acta Haematologica|January 1, 1996
Role of anthracyclines in the treatment of adult acute lymphoblastic leukemiaR Bassan, T Lerede, A Rambaldi, et al.British Journal of Haematology|August 1, 1983
Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza')T Barbui, G Finazzi, F Rodeghiero, et al.La Ricerca in Clinica E in Laboratorio|January 1, 1981
Spectrum of platelet aggregation abnormalities in myeloproliferative diseasesS Cortelazzo, P Viero, R Bassan, et al.Blood|January 15, 1996
All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4)A Falanga, M Marchetti, S Giovanelli, et al.Thrombosis and Haemostasis|October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseasesP Viero, S Cortelazzo, R Bassan, et al.Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiencyT Barbui, G Cartei, T Chisesi, et al.Thrombosis and Haemostasis|June 18, 1980
Abnormal aggregation and increased size of platelets in myeloproliferative disordersS Cortelazzo, T Barbui, R Bassan, et al.Leukemia & Lymphoma|September 1, 1996
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia veraR Marchioli, R Landolfi, T Barbui, et al.Leukemia|July 30, 2003
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cellsA Falanga, A Vignoli, M Marchetti, et al.British Journal of Haematology|November 1, 1991
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpuraA Falanga, R Consonni, P Ruggenenti, et al.Pageof 29